Many conferences are not worth the time spent—I left this one smarter and more connected than when I arrived.”
Drug Channels Leadership Forum
Drug Channels Leadership Forum
The Future of the Drug Channel Starts Here
An invitation-only, curated experience for senior leaders and decision-makers shaping the future of the drug channel.
- Unfiltered insights into the market dynamics reshaping the drug channel
- Strategies for navigating the most important challenges facing industry leaders
- Candid perspectives from an intentionally curated group of industry experts
Join Us March 15-17, 2027 in Miami
Get More Information
No spam. Unsubscribe anytime.
Candid. Consequential. Conversations shaping the future of the drug channel.
Featuring candid conversations with industry leaders, innovators, and policymakers on the forces reshaping the U.S. pharmaceutical ecosystem.
The Drug Channels Leadership Forum returns for its third year, bringing together a curated group of senior leaders and decision-makers to examine the most consequential issues shaping the U.S. drug channel. Join peers from across the industry for candid discussion, new perspectives, and insights you can take back to your organization.
March 15–17, 2027
JW Marriott Miami Turnberry Resort and Spa
Miami, Florida
DCLF Host and Moderator
As DCLF host and moderator, Antonio will lead candid conversations with industry leaders throughout the 2027 program.
Born and raised in the world of pharmacy, Antonio Ciaccia has spent his career studying the prescription drug marketplace. During his time at the Ohio Pharmacists Association, his data analytics work helped state officials uncover $244 million in hidden prescription drug overcharges in Ohio’s Medicaid managed care program. Today, he is President of 3 Axis Advisors, a consulting firm that helps public and private organizations identify inefficiencies and misaligned incentives in the prescription drug supply chain, and CEO and co-founder of 46brooklyn Research, a nonprofit dedicated to making drug pricing data more transparent and accessible.
Fireside Chats
Delve into the heart of industry trends and challenges with intimate fireside chats with industry thought leaders, analysts, and executives at the drug channels forefront.
Salon-Style Format
Experience a dynamic and interactive environment where ideas flow freely and collaboration thrives. Our salon-style approach fosters open dialogue and a meaningful exchange of perspectives. Engage in lively discussions and debates on the most pressing issues facing pharmaceutical distribution channels.
Provocative Discussions
Explore the most consequential issues facing the drug channel through candid discussion, competing perspectives, and practical insights.
Real, Candid Conversations.
DCLF tackles the most pressing issues facing the drug channel and asks the questions others often avoid.
Networking
Connect and cultivate relationships with thought leaders and solution providers that extend beyond the forum, further driving collaboration and growth.
Featured 2026 DCLF Speakers
-
Mark CubanEntrepreneur and Co-Founder | Cost Plus DrugsMark Cuban, a native of Pittsburgh, PA, a graduate of Indiana University... -
Debbie WeitzmanCEO, Pharmaceutical & Specialty Solutions | Cardinal HealthDebbie Weitzman is the chief executive officer of the Pharmaceutical and... -
Mostafa KamalPresident and Chief Executive Officer | Prime TherapeuticsAs president and CEO of Prime Therapeutics, Mostafa Kamal leads Prime and... -
Kevin Host, PharmDSenior Vice President, Pharmacy | WalmartKevin Host is Senior Vice President of Pharmacy at Walmart, which includes... -
Jeff DavisExecutive Director, National Channel | AstraZenecaJeff leads the National Channel Account Team, as part of the US Market... -
Christine G. Marsh, MBASenior Vice President, Value & Access | Boehringer IngelheimChristine (Chris) Marsh, Senior Vice President, currently leads the Value &... -
Jennifer NortonFormer Senior Vice President, Patient and Market Access | Takeda PharmaceuticalsJen Norton is the former Senior Vice President of U.S. Patient and Market...
Back to top